NEW YORK (GenomeWeb News) - Ibis Biosciences, a subsidiary of Isis Pharmaceuticals, said yesterday that has been awarded a $1.2 million subcontract from the National Institutes of Health to study how influenza viruses are transmitted.
 
Ibis is conducting the research through a subcontract with its partner the Lovelace Respiratory Research Institute. The grant will sponsor assay development and sample characterization for viruses including the H5N1 strain, which causes avian flu.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.